The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
R Machado-Vieira, J Baumann, C Wheeler-Castillo… - Pharmaceuticals, 2010 - mdpi.com
Currently available antidepressants used to treat major depressive disorder (MDD)
unfortunately often take weeks to months to achieve their full effects, commonly resulting in …
unfortunately often take weeks to months to achieve their full effects, commonly resulting in …
The pharmacology of putative early-onset antidepressant strategies
P Blier - European Neuropsychopharmacology, 2003 - Elsevier
Depression is a serious and burdensome illness. Although selective serotonin reuptake
inhibitors (SSRIs) have improved safety and tolerability of antidepressant treatment efficacy …
inhibitors (SSRIs) have improved safety and tolerability of antidepressant treatment efficacy …
Convergent mechanisms underlying rapid antidepressant action
Traditional pharmacological treatments for depression have a delayed therapeutic onset,
ranging from several weeks to months, and there is a high percentage of individuals who …
ranging from several weeks to months, and there is a high percentage of individuals who …
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.
R Machado-Vieira, G Salvadore… - Journal of Clinical …, 2008 - psychiatrist.com
Objective: Current therapeutics of depression are similar in their time to antidepressant
action and often take weeks to months to achieve response and remission, which commonly …
action and often take weeks to months to achieve response and remission, which commonly …
Evidence of early onset of antidepressant effect in randomized controlled trials
SM Stahl, AA Nierenberg… - Journal of Clinical …, 2001 - psychiatrist.com
Although antidepressant medications are effective in approximately 70% of patients with
major depressive disorder, they have a delayed onset of therapeutic effect. This latency is …
major depressive disorder, they have a delayed onset of therapeutic effect. This latency is …
Accelerating response to antidepressant treatment in depression: a review and clinical suggestions
S Nakajima, T Suzuki, K Watanabe, H Kashima… - Progress in Neuro …, 2010 - Elsevier
OBJECTIVE: The primary objective of this article is to review the literature regarding the
speed of response to antidepressant drugs and potential strategies to accelerate the …
speed of response to antidepressant drugs and potential strategies to accelerate the …
Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs
MM Katz, SH Koslow, A Frazer - Depression and anxiety, 1996 - Wiley Online Library
The question of when antidepressant drugs (AD) initiate significant clinical actions in
depressed patients is still unsettled. Findings from early studies on whether there is a lag in …
depressed patients is still unsettled. Findings from early studies on whether there is a lag in …
Onset, time course and trajectories of improvement with antidepressants
RW Lam - European Neuropsychopharmacology, 2012 - Elsevier
There is still considerable controversy about the onset and time course of improvement with
antidepressants in the treatment of major depressive disorder. Previous studies suggested a …
antidepressants in the treatment of major depressive disorder. Previous studies suggested a …
Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses
HH Stassen, J Angst, A Delini-Stula - Pharmacopsychiatry, 1996 - thieme-connect.com
The onset of action of antidepressant drugs was investigated on the basis of two
independent, multicenter, double-blind studies, comparing amitriptyline (N= 120) …
independent, multicenter, double-blind studies, comparing amitriptyline (N= 120) …
Faster, better, stronger: towards new antidepressant therapeutic strategies
Major depression is a highly prevalent disorder and is predicted to be the second leading
cause of disease burden by 2020. Although many antidepressant drugs are currently …
cause of disease burden by 2020. Although many antidepressant drugs are currently …